Micropapillary serous carcinoma of the ovary: cytomorphologic characteristics in peritoneal/pelvic washings.

Abstract:

BACKGROUND:Micropapillary serous carcinoma (MPSC), a recently described entity, is an ovarian tumor with a distinctive histologic architecture that lacks a destructive infiltrative growth pattern and behaves like a low-grade neoplasm. The purpose of this study was to determine if specific cytomorphologic features were associated with this tumor in peritoneal/ pelvic washings. METHODS:Eight cases of MPSC were retrieved from the cytopathology files at The Johns Hopkins Hospital. Patients ranged in age from 31 to 74 years (mean, 58 years). A cytomorphologic comparison was made with pelvic washings of eight cases of papillary serous carcinoma (PSC) of the ovary. RESULTS:MPSC demonstrated small but well formed papillary fragments (generally < 30 cells) composed of monotonous, relatively small epithelial cells, often with multiple nucleoli. Single, large atypical cells were seldom present and were seen in less than one half of cases. Cellularity was generally high and slide background was clear with minimal inflammatory cells. In comparison, PSC, in addition to the smaller papillary fragments, also exhibited larger more complex papillary fragments (generally > 30 cells) composed of pleomorphic, hyperchromatic cells often with single prominent nucleoli. Single, large tumor cells exhibiting eccentric atypical nuclei or multinucleation were present in high concentration in the majority of PSCs. Psammoma bodies were observed in one half of cases in both tumor types. CONCLUSIONS:Although MPSC shares cytomorphologic similarities with PSC, it can be diagnosed adequately in peritoneal/ pelvic washings. Careful interpretation of the subtle cytologic differences seen in the two tumor types may facilitate the differentiation of these neoplasms for a more appropriate management of the patient.

journal_name

Cancer

journal_title

Cancer

authors

Alli PM,Ali SZ

doi

10.1002/cncr.10619

subject

Has Abstract

pub_date

2002-06-25 00:00:00

pages

135-9

issue

3

eissn

0008-543X

issn

1097-0142

journal_volume

96

pub_type

杂志文章

相关文献

CANCER文献大全
  • Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.

    abstract:BACKGROUND:Patient safety is a critical concern in clinical oncology, but the ability to measure adverse events (AEs) across cancer care is limited by a narrow focus on treatment-related toxicities. The objective of this study was to assess the nature and extent of AEs among cancer patients across inpatient and outpati...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30916

    authors: Lipitz-Snyderman A,Pfister D,Classen D,Atoria CL,Killen A,Epstein AS,Anderson C,Fortier E,Weingart SN

    更新日期:2017-12-01 00:00:00

  • A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A Mid-Atlantic Oncology Program study.

    abstract::One hundred eighty-four patients with advanced measurable colorectal cancer not previously treated with chemotherapy were entered into a prospective randomized clinical trial by the Mid-Atlantic Oncology Program (MAOP) to assess the value of weekly cisplatin (20 mg/m2) when added to a protracted schedule of 5-fluorour...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1002/1097-0142(19910101)67:1<14::aid-cncr282067

    authors: Lokich JJ,Ahlgren JD,Cantrell J,Heim WJ,Wampler GL,Gullo JJ,Fryer JG,Alt DE

    更新日期:1991-01-01 00:00:00

  • Detection of humoral immune response to human brain tumors: specificity and reliability of microcytotoxicity assay.

    abstract::A humoral microcytotoxicity assay has been used to study the immune response to human malignant astrocytic tumors. Two series are described. When the assay was performed under uniform, ideal conditions, the sera from 36 of 45 patients with these tumors (80%) produced significant cytotoxicity against allogeneic astrocy...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197901)43:1<86::aid-cncr28204301

    authors: Wood WC,Kornblith PL,Quindlen EA,Pollock LA

    更新日期:1979-01-01 00:00:00

  • Amyloid stroma in a tubular carcinoma of palatal salivary gland: a histochemical and ultrastructural study.

    abstract::Amyloid as defined by positive Congo red green birefringence and STB red birefringence was observed in the stroma of a tubular carcinoma of minor salivary gland origin. The amyloid exhibited additional histochemical characteristics of immunamyloid, viz., positive DMAB-nitrate and DC-reactions and spontaneous autofluor...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197805)41:5<1836::aid-cncr282041

    authors: David R,Buchner A

    更新日期:1978-05-01 00:00:00

  • Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck.

    abstract::Forty-four patients with advanced carcinoma of the head and neck were treated with cyclophosphamide, 400 mg/m2 plus BCNU, 100 mg/m2 day 1 followed by adriamycin 40 mg/m2 day 2, with therapy repeated every 4 weeks. Of 31 evaluable patients, there were 1 complete response, and 10 partial responses (35%). Four of 8 patie...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197911)44:5<1571::aid-cncr282044

    authors: Presant CA,Ratkin G,Klahr C,Brown C

    更新日期:1979-11-01 00:00:00

  • Mitomycin in metastatic breast cancer refractory to hormonal and combination chemotherapy.

    abstract::Forty-three patients with evaluable metastatic breast cancer refractory to hormonal agents and extensive combination chemotherapy including doxorubicin were treated with mitomycin, 20 mg/m2 intravenously every 6 weeks. There were five partial responses (12%) and three minor responses (7%), with a mean time to progress...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19851115)56:10<2381::aid-cncr282

    authors: Pasterz RB,Buzdar AU,Hortobagyi GN,Blumenschein GR

    更新日期:1985-11-15 00:00:00

  • Chemoprevention: drug pricing and mortality: the case of tamoxifen.

    abstract:BACKGROUND:Tamoxifen is a prototypic cancer chemopreventive agent, yet clinical trials have not evaluated its effect on mortality or the impact of drug pricing on its cost-effectiveness. METHODS:A state-transition Markov model for a hypothetical cohort of women age 50 years was used to evaluate the effects of tamoxife...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22075

    authors: Melnikow J,Kuenneth C,Helms LJ,Barnato A,Kuppermann M,Birch S,Nuovo J

    更新日期:2006-09-01 00:00:00

  • Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival?

    abstract:BACKGROUND:For many childhood cancers, survival is lower among non-Hispanic blacks and Hispanics in comparison with non-Hispanic whites, and this may be attributed to underlying socioeconomic factors. However, prior childhood cancer survival studies have not formally tested for mediation by socioeconomic status (SES). ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31560

    authors: Kehm RD,Spector LG,Poynter JN,Vock DM,Altekruse SF,Osypuk TL

    更新日期:2018-10-15 00:00:00

  • Pinealoma. A report of twelve irradiated cases.

    abstract::The records of 12 patients with a diagnosis of pinealoma or ectopic pinealoma irradiated at Montefiore Hospital and Medical Center between 1961 and 1971 were reviewed. Diagnosis was made clinically and radiographically. Histology is available in three cases. Eight cases were treated with small fields (4 X 4 to 6 X 8 c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197606)37:6<2713::aid-cncr282037

    authors: Mincer F,Meltzer J,Botstein C

    更新日期:1976-06-01 00:00:00

  • Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.

    abstract:BACKGROUND:To the authors' knowledge, relatively little is known regarding the interaction of risk factors for hepatocellular carcinoma (HCC) with age, sex, and liver disorder status. METHODS:The authors followed 504,646 Korean patients aged 40 to 80 years who underwent routine health checkups between 2002 and 2003 un...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31406

    authors: Yi SW,Choi JS,Yi JJ,Lee YH,Han KJ

    更新日期:2018-07-01 00:00:00

  • Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas.

    abstract:BACKGROUND:The purpose of this study was to identify biologic differences between ovarian clear cell carcinoma and other ovarian adenocarcinomas by comparing the expression of cell cycle regulatory molecules and by analyzing the survival of the patients. METHODS:In 51 cases of epithelial ovarian carcinoma, the express...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19990201)85:3<669::aid-cnc

    authors: Shimizu M,Nikaido T,Toki T,Shiozawa T,Fujii S

    更新日期:1999-02-01 00:00:00

  • Glucocorticoid receptors in hepatocellular carcinoma and adjacent liver tissue.

    abstract::Glucocorticoid and progesterone receptors, tyrosine aminotransferase, gamma-glutamyltransferase and alpha-fetoprotein levels were determined in human hepatocellular carcinoma (HCC) and adjacent liver tissues. Glucocorticoid receptor was present in seven of ten HCC samples, values ranged from 1.9 to 66.8 fmol/mg protei...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19881115)62:10<2134::aid-cncr282

    authors: P'eng FK,Lui WY,Chang TJ,Kao HL,Wu LH,Liu TY,Chi CW

    更新日期:1988-11-15 00:00:00

  • The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.

    abstract:BACKGROUND:In a randomized Phase II study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin C (PAM) combination, that includes cisplatin (P) instead of 5-fluorouracil as in the 5-fluorouracil, doxorubicin, and mitomycin C (FAM) combination, in patients with advanced gastr...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1002/(SICI)1097-0142(19960115)77:2<245::AID-CNC

    authors: De Lisi V,Cocconi G,Angelini F,Cavicchi F,Di Costanzo F,Gilli G,Rodinò C,Soldani M,Tonato M,Finardi C

    更新日期:1996-01-15 00:00:00

  • Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape.

    abstract:BACKGROUND:Fas (CD95/APO-1) and Fas ligand (FasL) play key roles in immunologic homeostasis and immune privilege and may regulate normal cell turnover. Earlier studies had suggested that FasL-positive pancreatic carcinoma cell lines can induce apoptosis in T cells, thereby evading host immune surveillance. In the curre...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10549

    authors: Bernstorff WV,Glickman JN,Odze RD,Farraye FA,Joo HG,Goedegebuure PS,Eberlein TJ

    更新日期:2002-05-15 00:00:00

  • Prognosis for primary retroperitoneal sarcoma survivors: a conditional survival analysis.

    abstract:BACKGROUND:The AJCC staging system and post-operative nomograms use patient and tumor characteristics to provide prognostic estimates after resection of retroperitoneal sarcoma (RPS). While these variables help to predict survival at the time of diagnosis and resection, the applicability of these prognostic factors to ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26665

    authors: Abbott AM,Habermann EB,Parsons HM,Tuttle T,Al-Refaie W

    更新日期:2012-07-01 00:00:00

  • Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.

    abstract::On the basis of previous findings at this institution, VM-26 and Cytosine Arabinoside (ara-C) were used in combination to treat 33 children with refractory acute lymphocytic leukemia (ALL). Chemotherapy was given by vein twice a week for four weeks at dosage of 300 mg/m2 for ara-C and 50, 75, 110, 165, or 200 mg/m2 fo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800315)45:6<1284::aid-cncr2820

    authors: Rivera G,Aur RJ,Dahl GV,Pratt CB,Wood A,Avery TL

    更新日期:1980-03-15 00:00:00

  • The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age.

    abstract:BACKGROUND:Previous data from the National Cancer Data Base have examined time trends in stage of disease, treatment patterns, and survival for selected cancers. The most current (1993) data for breast carcinoma are described here. METHODS:Five Calls for Data have yielded a total of 508,724 breast cancer cases diagnos...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19961015)78:8<1838::aid-cn

    authors: Winchester DP,Osteen RT,Menck HR

    更新日期:1996-10-15 00:00:00

  • High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.

    abstract:BACKGROUND:Desmoid tumors are mesenchymal nonmetastasizing neoplasms. Although rare in the general population, they are a common extracolonic manifestation of familial adenomatous polyposis (FAP). Because of high tumor recurrence rates, surgery has been less than satisfactory in the treatment of desmoid tumors. In the ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11937

    authors: Hansmann A,Adolph C,Vogel T,Unger A,Moeslein G

    更新日期:2004-02-01 00:00:00

  • Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.

    abstract::Mitomycin C (MMC) has been evaluated in combination with several antitumor agents. Full dose response curves were established for all drugs and drug combinations. Synergy was shown with MMC plus either cyclophosphamide (CYC) or methotrexate (MTX). In testing MMC and CYC against P388 leukemia, the combined treatment yi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830215)51:4<600::aid-cncr28205

    authors: Mabel JA,Wodinsky I

    更新日期:1983-02-15 00:00:00

  • Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative.

    abstract:BACKGROUND:Melanoma is the most lethal form of skin cancer, with an estimated 68,130 new cases and 8700 deaths in the United States in 2010. The increasing incidence and high death rate associated with metastatic disease support the need to focus on prevention. The authors used data from the Women's Health Initiative (...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27497

    authors: Jagtap D,Rosenberg CA,Martin LW,Pettinger M,Khandekar J,Lane D,Ockene I,Simon MS

    更新日期:2012-10-15 00:00:00

  • Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.

    abstract::Since June 1978, 57 patients with primary osteogenic sarcoma of an extremity were treated with high-dose methotrexate (HDMTX) and citrovorum factor rescue (CFR), Adriamycin, and the combination of bleomycin, cyclophosphamide and dactinomycin (BCD) given for 4-16 weeks prior to definitive surgery. Histologic examinatio...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820315)49:6<1221::aid-cncr2820

    authors: Rosen G,Caparros B,Huvos AG,Kosloff C,Nirenberg A,Cacavio A,Marcove RC,Lane JM,Mehta B,Urban C

    更新日期:1982-03-15 00:00:00

  • Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.

    abstract:BACKGROUND:The growing number of individuals surviving childhood cancer has increased the awareness of adverse long-term sequelae. One of the most worrisome complications after cancer therapy is the development of second malignant neoplasms (SMNs). METHODS:The authors describe the incidence of solid organ SMN in survi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23860

    authors: Goldsby R,Burke C,Nagarajan R,Zhou T,Chen Z,Marina N,Friedman D,Neglia J,Chuba P,Bhatia S

    更新日期:2008-11-01 00:00:00

  • Disseminated intravascular coagulation in childhood acute lymphocytic leukemia with poor prognostic features.

    abstract::Three children with ALL having poor prognostic features developed clinical and laboratory evidence of disseminated intravascular coagulation (DIC). Two developed a bleeding diathesis associated temporally with a rapid drop in blast cell counts during induction therapy with L-asparaginase, prednisone, and vincristine. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197804)41:4<1642::aid-cncr282041

    authors: Champion LA,Luddy RE,Schwartz AD

    更新日期:1978-04-01 00:00:00

  • Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinoma.

    abstract::Cis-diamminedichloride platinum II (DDP) was administered to eight patients with epidermoid carcinoma of the penis. Three of six adequately treated patients had an objective response: one patient achieved complete remission of 7 months duration and 2 patients had partial remissions of 8 and 2 months, respectively. DDP...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197911)44:5<1563::aid-cncr282044

    authors: Sklaroff RB,Yagoda A

    更新日期:1979-11-01 00:00:00

  • Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients.

    abstract:BACKGROUND:The importance of the bone marrow microenvironment in multiple myeloma is receiving increasing attention. Recent studies have suggested the importance of cytokine production and cell-cell contact by bone marrow stromal cells in the survival of myeloma cells. METHODS:In the current study, the authors examine...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010401)91:7<1219::aid-cncr1122

    authors: Wallace SR,Oken MM,Lunetta KL,Panoskaltsis-Mortari A,Masellis AM

    更新日期:2001-04-01 00:00:00

  • Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.

    abstract:BACKGROUND:The purported lack of long term modern prostate brachytherapy outcome data continues to lead many physicians to recommend other, more traditional treatments. This concern for long term results has encouraged the authors to supplement their earlier 10-year follow-up of patients receiving brachytherapy; in the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Ragde H,Korb LJ,Elgamal AA,Grado GL,Nadir BS

    更新日期:2000-07-01 00:00:00

  • Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.

    abstract:BACKGROUND:Acute myeloid leukemia (AML) with t(6;11)(q27;q23) is a well established but rare entity, and few studies have reported the full clinical, hematologic, and outcome data of patients with this disease. METHODS:To characterize the features of t(6;11) AML, the authors searched the Cancer and Leukemia Group B (C...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.20489

    authors: Blum W,Mrózek K,Ruppert AS,Carroll AJ,Rao KW,Pettenati MJ,Anastasi J,Larson RA,Bloomfield CD

    更新日期:2004-09-15 00:00:00

  • Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.

    abstract::One hundred fifty-six evaluable patients with metastatic breast cancer were treated with vincristine, Adriamycin and cyclophosphamide alternating at fixed intervals with 5-FU and methotrexate. Immunotherapy with BCG or MER-BCG was administered to all patients in two consecutive treatment programs. Overall objective re...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19800215)45:4<742::aid-cncr28204

    authors: Blumenschein GR,Hortobagyi GN,Richman SP,Gutterman JU,Tashima CK,Buzdar AU,Burgess MA,Livingston RB,Hersh EM

    更新日期:1980-02-15 00:00:00

  • The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer.

    abstract:BACKGROUND:Transforming growth factor beta (TGFbeta) is important in colorectal cancer (CRC) progression. Bone morphogenetic proteins (BMPs), a subgroup within the TGFbeta superfamily, recently also have been implicated in CRC, but their precise role in CRC has yet to be investigated. METHODS:The authors used a tissue...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23160

    authors: Kodach LL,Bleuming SA,Musler AR,Peppelenbosch MP,Hommes DW,van den Brink GR,van Noesel CJ,Offerhaus GJ,Hardwick JC

    更新日期:2008-01-15 00:00:00

  • Sequential identification of factors predicting distant relapse in breast cancer patients treated by conservative surgery.

    abstract:BACKGROUND AND METHODS:Predictors of distant relapse following conservative surgery for breast cancer were studied in a review of 425 women. Five steps of breast cancer patient management were defined in which increasing amounts of information, potentially relevant to prognosis for metastasis-free survival (MFS), were ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19930815)72:4<1261::aid-cncr2820

    authors: Tubiana-Hulin M,Le Doussal V,Hacene K,Rouëssé J,Brunet M

    更新日期:1993-08-15 00:00:00